Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bioventus (BVS) Non Operating Income (2020 - 2025)

Historic Non Operating Income for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to -$6.6 million.

  • Bioventus' Non Operating Income rose 2609.48% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$30.7 million, marking a year-over-year increase of 2125.92%. This contributed to the annual value of -$37.1 million for FY2024, which is 568.48% up from last year.
  • According to the latest figures from Q3 2025, Bioventus' Non Operating Income is -$6.6 million, which was up 2609.48% from -$8.1 million recorded in Q2 2025.
  • Over the past 5 years, Bioventus' Non Operating Income peaked at $2.5 million during Q2 2021, and registered a low of -$16.8 million during Q4 2022.
  • Over the past 5 years, Bioventus' median Non Operating Income value was -$8.1 million (recorded in 2025), while the average stood at -$6.5 million.
  • In the last 5 years, Bioventus' Non Operating Income surged by 19971.59% in 2021 and then plummeted by 430075.0% in 2022.
  • Over the past 5 years, Bioventus' Non Operating Income (Quarter) stood at $400000.0 in 2021, then plummeted by 4300.75% to -$16.8 million in 2022, then soared by 43.04% to -$9.6 million in 2023, then grew by 18.96% to -$7.8 million in 2024, then increased by 15.14% to -$6.6 million in 2025.
  • Its Non Operating Income stands at -$6.6 million for Q3 2025, versus -$8.1 million for Q2 2025 and -$8.3 million for Q1 2025.